Author

Anna Hudson

University of Miami

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Ashish H Shah· 1 shared Bradley H. GampeliD· 1 shared Christian Kieran RamsoomairiD· 1 shared Daniel Diniz De CarvalhoiD· 1 shared Danny ReinbergiD· 1 shared Deepa SeetharamiD· 1 shared Defne BayıkiD· 1 shared Felipe Sarmiento· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ashish H Shah

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting an RNA Editor to Impede H3K27M+ Pediatric Gliomas

Christian Kieran Ramsoomair, Victoria Álvarez, Felipe Sarmiento, Manuela Aramburu Berckemeyer, Deepa Seetharam, Kajol Kalliecharan, Sreerag N. Moorkkannur, Jonathan Mitchell, Anna Hudson, Justin Taylor, Michele Ceccarelli, Defne Bayık, Oren Josh Becher, Rajeev Prabahakar, Scott M. Welford, , Ashish H Shah

This study identifies ADAR as a key mediator of immune evasion in H3K27M+ pediatric gliomas and shows that ATRA can induce ADAR degradation, enhancing antiviral responses and tumor immunogenicity.

bioRxiv · May 12, 2026 · PreprintCancer Biology